<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-07</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-07</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>51</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯åœ¨è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆå¦‚ä¹³è…ºç™Œã€è‚ ä¸Šçš®ï¼‰åŠç¥ç»ç³»ç»Ÿï¼ˆå¦‚æµ·é©¬ã€è‚ ç¥ç»ç³»ç»Ÿï¼‰ç ”ç©¶ä¸­å±•ç°å‡ºå‰æ‰€æœªæœ‰çš„åˆ†è¾¨ç‡ï¼Œæ­ç¤ºäº†ç»†èƒé—´äº’ä½œå’Œå¼‚è´¨æ€§ã€‚miR-18aåœ¨é»‘è‰²ç˜¤æ²»ç–—è€è¯æœºåˆ¶ä¸­çš„ä½œç”¨è¢«é˜æ˜ï¼Œä¸ºé¶å‘æ²»ç–—æä¾›äº†æ–°æ€è·¯ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å¼‚è´¨æ€§ä¸æ²»ç–—è€è¯ï¼šè§£æä¸‰é˜´æ€§ä¹³è…ºç™Œã€é»‘è‰²ç˜¤ã€è‚ç»†èƒç™Œç­‰è‚¿ç˜¤ä¸­ï¼Œç»†èƒå¼‚è´¨æ€§ã€å…ç–«ç»†èƒä»¥åŠè‚¿ç˜¤å¾®ç¯å¢ƒå¦‚ä½•é©±åŠ¨æ²»ç–—æŠµæŠ—ã€‚<br />
- ç»†èƒå¯å¡‘æ€§ä¸å¹²ç»†èƒç”Ÿç‰©å­¦ï¼šç ”ç©¶ä¸Šçš®ç»†èƒã€ç¥ç»å…ƒç­‰åœ¨å‘è‚²ã€è¡°è€å’Œç–¾ç—…ï¼ˆå¦‚è‚¿ç˜¤å‘ç”Ÿï¼‰è¿‡ç¨‹ä¸­çš„å»åˆ†åŒ–ã€é‡ç¼–ç¨‹åŠå¹²ç»†èƒå¾®ç¯å¢ƒè°ƒæ§ã€‚<br />
- ç¥ç»é€€è¡Œæ€§ç–¾ç—…æœºåˆ¶ï¼šé€šè¿‡å¤šç»„å­¦æ‰‹æ®µæ¢ç©¶é˜¿å°”èŒ¨æµ·é»˜ç—…ã€å¸•é‡‘æ£®ç—…ç­‰ç¥ç»é€€è¡Œæ€§ç–¾ç—…çš„å…±åŒç—…ç†æœºåˆ¶åŠæµ·é©¬ä½“æŸä¼¤ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>ç©ºé—´è½¬å½•ç»„å­¦ (Spatial Transcriptomics)</strong>ï¼šå®ç°ç»„ç»‡å†…ç»†èƒçš„é«˜åˆ†è¾¨ç‡åŸºå› è¡¨è¾¾åˆ†æï¼Œæ­ç¤ºå¾®ç¯å¢ƒå’Œç»†èƒç©ºé—´æ’å¸ƒå¯¹åŠŸèƒ½çš„å½±å“ã€‚<br />
- <strong>å•ç»†èƒè½¬å½•ç»„å­¦ (scRNA-seq)</strong>ï¼šæ·±å…¥è§£æç»†èƒå±‚é¢çš„å¼‚è´¨æ€§ï¼Œè¯†åˆ«ç¨€æœ‰ç»†èƒäºšç¾¤åŠå…¶åœ¨ç–¾ç—…å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡ç»˜åˆ¶å‡ºé©±åŠ¨ç™Œç—‡ç”Ÿé•¿çš„å…³é”®åŸºå› çªå˜å…¨å›¾ï¼›æ–°å‹é¼»å–·ç–«è‹—å¯¹H5N1ç¦½æµæ„Ÿå±•ç°å¼ºæ•ˆä¿æŠ¤ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç™Œç—‡åŸºå› çªå˜æœºåˆ¶è§£æ<br />
- ç¦½æµæ„Ÿç—…æ¯’ç–«è‹—ç ”å‘</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å…¨é¢æµ‹è¯•å…³é”®åŸºå› çƒ­ç‚¹åŒºåŸŸçš„æ¯ä¸€ç§å¯èƒ½çªå˜<br />
- å¼€å‘æ–°å‹é¼»å–·å¼ç–«è‹—ä»¥åº”å¯¹äººé™…ä¼ æ’­é£é™©</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (49æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE294252 ç‚ç—‡å’Œæ¶ˆé€€ç¨‹åºæ€§é«“ç³»å›è·¯è°ƒæ§ä¸Šçš®æ€§å’Œé—´è´¨æ€§ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„æ²»ç–—è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammationã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Liqun Yu ; Xiang ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSingle-cell analysis of human triple-negative breast cancer revealed heterogeneous macrophage populations with opposing phenotypesâ€”pro-inflammatory and pro-resolution of inflammation. Paradoxically, both subsets accumulated in therapy-refractory residual tumors but showed inverse correlations across patients, suggesting mutually exclusive resistance mechanisms. Inflammatory macrophages localized preferentially to epithelial-like tumors, whereas pro-resolution macrophages were enriched in mesenchymal-like tumors. Mouse models faithfully recapitulated these patterns. After chemo-immunotherapy, mesenchymal-like tumors expanded pro-resolution macrophages through phagocytosis/efferocytosis, Ï‰-3 fatty-acid uptake, and resolvin production. Macrophage-secreted C1q emerged as a principal antagonist of T-cell function by targeting mitochondria and inducing metabolic dysfunction. By contrast, epithelial-like tumors accumulated inflammatory macrophages and neutrophils that produced prostaglandins via Ï‰-6 fatty-acid pathways. Knocking down ELOVL5â€”an elongase involved in Ï‰-3 and Ï‰-6 metabolismâ€”mitigated both neutrophil- and macrophage-mediated immunosuppression. These distinct axes, driven by dysregulated inflammation and resolution programs, converged to undermine therapy-induced immunosurveillance; however, targeting their shared upstream regulators may overcome these resistance mechanisms.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294252" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE318353 å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºäº†é»‘è‰²ç´ ç˜¤ä¸­ miR-18a ä»‹å¯¼çš„é¶å‘æ²»ç–—å’Œå…ç–«æ²»ç–—è€è¯æ€§çš„å¼‚è´¨æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:immuno(logy|therapy|suppression)ã€resistanceã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensIn melanoma, the knockout of miR-18a not only leads to resistance to monotherapy with BRAF inhibitors but also to combined therapy with BRAF and MEK inhibitors. This resistance is achieved by promoting the expression of YAP in the Hippo pathway. Additionally, the knockout of miR-18a results in high expression of THBS1-CD47, which causes T cell tolerance. miR-18a is regulated by hnRNPA1, and patients with low expression of miR-18a and hnRNPA1 have poorer Event-Free Survival (EFS).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318353" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE315587 åŸä½ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºäº†è§’è†œç¼˜å¹²ç»†èƒå¾®ç¯å¢ƒå’Œçœ¼è¡¨ä¸Šçš®çš„æ–°æ ‡å¿—ç‰©</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lamia Nureen ; Antonietta Salerno ; Orazio Vittorio ; Nick Di GirolamoSeries Type : OtherOrganism : Mus musculusThe mammalian cornea is endowed with stem cells (SCs) that have lifelong regenerative activity for its stratified epithelium. The niche for these cells is the limbus, and damage to this microstructure or its SCs results in a blinding disease known as limbal stem cell deficiency (LSCD). Despite the numerous studies that employ single-cell RNA sequencing, the identity of these cells remains an enigma principally because their spatial positioning is lost upon dissociation from their repository, and their gene expression is altered upon exposure to physical and chemical stressors during procurement. Herein, these adversities were avoided by conducting spatial transcriptomic screening directly on corneal, limbal and conjunctival tissues. Differentially expressed genes in the limbus included Krt16 and Nkiras1 among 6 others, which play a role in maintaining stemness, epithelial organization, immune surveillance, and tumor suppression. Krt16 was dynamically expressed in the developing limbus, correlated with slow-cycling label-retaining limbal epithelia and was induced during corneal injury; observations consistent with marking functional SCs. Additionally, we established Nkiras1 as a novel maker of neutrophils in the limbal SC niche, and Alox12e as a specific marker of conjunctival epithelia. Because current gold standard treatments for LSCD include SC transplantation, our data will inform future studies in delivering a more reliable standard therapy which incorporates an identifiable SC population to improve clinical outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315587" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE288888 æµ·é©¬ç¡¬åŒ–ä¸æ­£å¸¸æµ·é©¬çš„ç©ºé—´è½¬å½•ç»„å­¦ã€ç»„ç»‡ç—…ç†å­¦å’Œç£å…±æŒ¯äºšåŒºåˆ†å‰²æ¯”è¾ƒï¼šä¸€é¡¹æ¦‚å¿µéªŒè¯ç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samuel Guzman ; Ken Jones ; Saman HazanySeries Type : OtherOrganism : Homo sapiensDespite recent major advances in work-up and treatment of Drug Resistant Mesial Temporal Lobe Epilepsy (MTLE) with Hippocampal Sclerosis (HS), the underlying pathophysiology of this disease remains elusive. Depending on the type of HS, as defined by the histopathologic International League Against Epilepsy (ILAE), studies report variable post-surgical seizure freedom durations, with diverse underlying pathophysiology and gene expression. We here describe our initial experience with incorporating spatial transcriptomics along with Magnetic Resonance Imaging (MRI) and histopathology in a patient with Drug Resistant MTLE and HS compared to the hippocampus of an age-sex matched control case. Cases were assessed by MRI hippocampal subfields segmentation, neuropathology, and spatial transcriptomics to identify candidate genes that play a role in the biology of HS. A significant finding was a partial inhibition of the methyl-CpG-binding protein 2 (MeCP2) gene in all subfields of the hippocampus, which is important for neuronal survival and differentiation. Together, our results have shown the feasibility of hippocampal subfield segmentation on MRI and direct correlation with histology and spatial transcriptomics to identify key areas of gene dysregulation in epilepsy. These novel methods can be used to implement personalized medicine and discovery of new drug targets.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288888" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE288394 å»åˆ†åŒ–é©±åŠ¨çš„è‡´ç™Œå¹²æ€§ä¿ƒè¿›è‚ ä¸Šçš®ç»†èƒç»´æŒè‚¿ç˜¤çš„é€‚åº”æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€regex:onco(logy|logist|gene|genic)ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kylee Zgeib ; Thompson Hui ; Atharva Inamdar ; Ansu Perekatt ; Simon Garcia ; Binfeng Lu ; Crysta Lim ; Shima Nejati ; Amartya Singh ; Zahra Hashemi ; Dahlia Matouba ; Christina LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal tumors can arise either from mutations sustained in Lgr5âº stem cells (bottom-up) or through dedifferentiation of lineage-committed epithelial cells (top-down). Using a Smad4 loss-of-function and Î²-catenin gain-of-function mutant mouse model, we show that dedifferentiation-derived stem cells sustain tumorigenesis more effectively than mutant Lgr5âº cells in the endogenous crypts. Bulk and single-cell RNA sequencing revealed transcriptional reprogramming and the emergence of oncogenic villus-derived stem-like cells. Complementary in vivo and organoid studies suggest that dedifferentiation-derived oncogenic stem cells possess superior tumor-initiating and sustaining capacity<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288394" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE288393 sc-RNA-seq ç ”ç©¶æ­ç¤ºäº†å»åˆ†åŒ–è‚ ä¸Šçš®ç»†èƒçš„è‡´ç™Œé‡ç¼–ç¨‹ä¸ºå¼‚è´¨å¹²ç»†èƒçŠ¶æ€ [æ•°æ®é›† 1]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€RNA-seqã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kylee Zgeib ; Thompson Hui ; Atharva Inamdar ; Ansu Perekatt ; Crystal Lim ; Shima Nejati ; Binfeng Lu ; Simon Garcia ; Zahra Hashemi ; Amartya Sigh ; Dahlia Matouba ; Christina LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal tumors can arise either from mutations sustained in Lgr5âº stem cells (bottom-up) or through dedifferentiation of lineage-committed epithelial cells (top-down). Using a Smad4 loss-of-function and Î²-catenin gain-of-function mutant mouse model, we show that dedifferentiation-derived stem cells sustain tumorigenesis more effectively than mutant Lgr5âº cells in the endogenous crypts. Bulk and single-cell RNA sequencing revealed transcriptional reprogramming and the emergence of oncogenic villus-derived stem-like cells. Complementary in vivo and organoid studies suggest that dedifferentiation-derived oncogenic stem cells possess superior tumor-initiating and sustaining capacity<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288393" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE313961 å†…çš®ç´ å’ŒCD44ä»‹å¯¼çš„å¼‚å‹ä¿¡å·ä¼ å¯¼ä»‹å¯¼è‚¿ç˜¤-åŸºè´¨ä¸²æ‰°å¹¶ä¿ƒè¿›è‚ç»†èƒç™Œçš„æ¶æ€§è¿›å±•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€carcinoma<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Woobeen Jo ; Chanho Park ; Min Kim ; Chu-Sook Kim ; Jungsun Yoo ; Sahee Kim ; Jiseon Shin ; Hyun-Woo Rhee ; Jiyoung ParkSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThis study profiles gene expression changes in the human SK-Hep1 cell line, a mesenchymal-like liver-derived cell model, under conditions of differential sorafenib responsiveness. Bulk RNA sequencing was performed on sorafenib-sensitive (SS) and sorafenib-resistant (SR) cells treated with control siRNA (siCtrl), COL6A3 siRNA (siCOL6A3), or siCOL6A3 combined with recombinent endotrophin (rhETP). The data were generated to characterize transcriptional patterns associated with altered proliferation-and survival-related phenotypes across defined experimental conditions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313961" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE303197 Dynamic Antigen Expression and Intrinsic CTL Resistance in HIV-1 Reservoir Clones</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šantigenã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Richard B Jones ; Alberto Herrera ; Paul ZumboSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensReservoirs of clonally expanded CD4+ T-cells harboring rebound-competent HIV-1 proviruses persist lifelong during ART. Latency is considered the principal barrier to viral eradication and has resisted pharmacological reversal, yet it appears that sustained immune pressure may still erode reservoirs. Recent advances have yielded glimpses into these exceptionally rare reservoir-harboring cells, implicating intrinsic pro-survival properties in their persistence. Here, we isolate and characterize populations of authentic reservoir clones (ARCs) that robustly proliferate and accumulate while producing infectious virus, without overtly succumbing to viral cytopathic effects. At any given moment, only small fractions of ARCs expressed HIV-1 proteins, a state remarkably unperturbed by potent TCR stimulation or latency-reversing agents. Nevertheless, sustained co-culture with cytotoxic T-lymphocytes (CTL) revealed extensive time-integrated antigenic vulnerability, culling clonal expansion of some ARCs by &gt;90%. Notably, one regulatory T-cell ARC displayed pronounced cell-intrinsic resistance to CTL â€“ a longstanding hypothesis we now directly demonstrate â€“ linked to low oxidative stress and reversed with desferoxamine, a hypoxic stress inducer and FDA-approved therapeutic. Overall, we provide novel insights into the vulnerabilities of reservoir clones to potent, sustained CTL pressure and highlight intrinsic resistance pathways as actionable therapeutic targets, opening opportunities for advancing immune-based HIV-1 cure strategies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303197" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE296017 ç™Œç—‡ã€åœ°å¡ç±³æ¾å’Œè¡°è€å¼•èµ·çš„éª¨éª¼è‚Œèç¼©ä¸»è¦ç”±ä¸åŒçš„ç¿»è¯‘åä¿®é¥°å¼•èµ·ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€aging<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Anna Stephan ; Yong-Dong Wang ; Fabio DemontisSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGene expression changes induced by LrpprcP27A vs. LrpprcWT in skeletal muscle<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296017" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE217516 æ”¯æ°”ç®¡æ‰©å¼ æ‚£è€…æ”¯æ°”ç®¡è‚ºæ³¡çŒæ´—æ¶²ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Elza Evren ; Tim WillingerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensBronchiectasis is a lung disease characterized by irreversible dilation of the large airways (bronchodilatation), which often causes recurrent airway infection and non-resolving inflammation. In this study, we performed single-cell RNA-sequencing (scRNA-seq) to determine the heterogeneity of immune cells in the airways of bronchiectasis patients.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217516" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 39 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ç§‘å­¦å®¶åˆšåˆšç»˜åˆ¶å‡ºäº†é©±åŠ¨ç™Œç—‡ç”Ÿé•¿çš„çªå˜å›¾è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that some changes barely boost cancer signals, while others supercharge them. When matched against real patient data, the map accurately predicted cancer behavior across tissues.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260204121540.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>æ–°å‹é¼»è…”ç–«è‹—å¯¹H5N1ç¦½æµæ„Ÿæ˜¾ç¤ºå‡ºå¼ºå¤§çš„ä¿æŠ¤ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼švaccine<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAs bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260204114343.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>7</td>
</tr>
<tr>
<td>resistance</td>
<td>6</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>6</td>
</tr>
<tr>
<td>sequencing</td>
<td>5</td>
</tr>
<tr>
<td>epigenome</td>
<td>5</td>
</tr>
<tr>
<td>single-cell</td>
<td>4</td>
</tr>
<tr>
<td>tumor</td>
<td>3</td>
</tr>
<tr>
<td>spatial</td>
<td>3</td>
</tr>
<tr>
<td>aging</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>2</td>
</tr>
<tr>
<td>scRNA</td>
<td>2</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>transcriptome</td>
<td>2</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>regex:intestin(e</td>
<td>al)</td>
</tr>
<tr>
<td>pathway</td>
<td>1</td>
</tr>
<tr>
<td>carcinoma</td>
<td>1</td>
</tr>
<tr>
<td>metabolic</td>
<td>1</td>
</tr>
<tr>
<td>antigen</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (39æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311781" target="_blank" rel="noopener noreferrer">GSE311781 ç ”ç©¶å‘ç°ï¼Œå±€ç¶æ€§ç™½è´¨ç—…å˜å¯å¯¼è‡´ç°è´¨ç‚ç—‡ã€ç¥ç»å…ƒåŠŸèƒ½éšœç¢å’Œçªè§¦ä¸¢å¤±ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318581" target="_blank" rel="noopener noreferrer">GSE318581 è½¬ç§»æ€§æ¿€ç´ æ•æ„Ÿæ€§å‰åˆ—è…ºç™Œä¸Šçš®å¼‚è´¨æ€§çš„å•ç»†èƒè½¬å½•ç»„å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318354" target="_blank" rel="noopener noreferrer">GSE318354 miR-18a CRISPR æ•²é™¤é»‘è‰²ç´ ç˜¤çš„è½¬å½•ç»„åˆ†æé‰´å®šå‡ºä¸æ²»ç–—è€è¯æ€§å’Œ T ç»†èƒæ€ä¼¤ç›¸å…³çš„åŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289920" target="_blank" rel="noopener noreferrer">GSE289920 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [é¶å‘æ‰©å¢å­æµ‹åº II]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289257" target="_blank" rel="noopener noreferrer">GSE289257 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [RNA-Seq,2]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288948" target="_blank" rel="noopener noreferrer">GSE288948 å·¨å™¬ç»†èƒ Smad1 å¯¼è‡´æ¢—æ­»ååŠŸèƒ½éšœç¢ï¼ŒæŠ‘åˆ¶è¡€ç®¡ç”Ÿæˆè¶‹åŒ–å› å­è¡¨è¾¾ï¼Œå¹¶åˆºæ¿€ç»†èƒå¤–åŸºè´¨é‡å¡‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255561" target="_blank" rel="noopener noreferrer">GSE255561 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255195" target="_blank" rel="noopener noreferrer">GSE255195 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [é¶å‘æ‰©å¢å­æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318477" target="_blank" rel="noopener noreferrer">GSE318477 ç§€ä¸½éšæ†çº¿è™«æ»è‚²å‘è‚²è¿‡ç¨‹ä¸­åŸºå› è¡¨è¾¾çš„é€šè·¯ç‰¹å¼‚æ€§é€šé“åŒ–å’Œå¯å¡‘æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303395" target="_blank" rel="noopener noreferrer">GSE303395 æ°§å›ºé†‡å—ä½“ GPR183 æ„ŸçŸ¥ä»£è°¢å¾®ç¯å¢ƒä¿¡å·ï¼Œä¿ƒè¿›å•æ ¸ç»†èƒåˆ†åŒ–ä¸ºç»„ç»‡é©»ç•™è‚ºå·¨å™¬ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303039" target="_blank" rel="noopener noreferrer">GSE303039 Elevated levels of Ube2g1 in hematopoietic stem cells lead to segmental aging of the hematopoietic system</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298718" target="_blank" rel="noopener noreferrer">GSE298718 è§£ç èƒ¶è´¨æ¯ç»†èƒç˜¤ä¾µè¢­ï¼šè‚¿ç˜¤èšé›†ä½“ä¸­ç¯å¢ƒå’Œç»†èƒå‘¨æœŸæ•ˆåº”çš„å•ç»†èƒåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298406" target="_blank" rel="noopener noreferrer">GSE298406 ç¥ç»å‘ç”Ÿé˜¶æ®µè‚ ç¥ç»ç³»ç»Ÿç¥–ç»†èƒæŸ“è‰²è´¨å¯åŠæ€§åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297618" target="_blank" rel="noopener noreferrer">å¯¹8å‘¨é¾„KPPC WTã€MAP3K7ff KPPCå’ŒMAP3K7fwt KPPCå°é¼ èƒ°è…ºè‚¿ç˜¤è¿›è¡ŒGSE297618å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318560" target="_blank" rel="noopener noreferrer">GSE318560 ç¥ç»é€€è¡Œæ€§ç—´å‘†ç—‡ï¼ˆé˜¿å°”èŒ¨æµ·é»˜ç—…ã€å”æ°ç»¼åˆå¾å’Œå¸•é‡‘æ£®ç—…ï¼‰æµ·é©¬ä½“çš„å…±åŒè‡´ç—…æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306150" target="_blank" rel="noopener noreferrer">GSE306150 ä¸»åŠ¨è„‰ç‚æ ·æœ¬çš„ç©ºé—´åŸºå› è¡¨è¾¾è°±åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300299" target="_blank" rel="noopener noreferrer">GSE300299 åŸºå­”è‚¯é›…ç—…æ¯’æŒç»­å­˜åœ¨äºå…³èŠ‚ç›¸å…³å·¨å™¬ç»†èƒä¸­ï¼Œå¹¶ä¿ƒè¿›æ…¢æ€§ç–¾ç—…çš„å‘ç”Ÿã€‚[scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318613" target="_blank" rel="noopener noreferrer">GSE318613 æ’æ²³çŒ´å¯¹ç–«è‹—çš„é€‚åº”æ€§å…ç–«ååº”åæ˜ äº†é¦–æ¬¡æ¥è§¦æ—¶çš„ç¤¾ä¼šåœ°ä½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318538" target="_blank" rel="noopener noreferrer">GSE318538 KIFC1æ•²ä½å¯¹H146å°ç»†èƒè‚ºç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318501" target="_blank" rel="noopener noreferrer">åŸºäº CRISPR ç­›é€‰çš„ GSE318501 miRNA-18a å¯è°ƒæ§é»‘è‰²ç´ ç˜¤ä¸­çš„é¶å‘æ²»ç–—è€è¯æ€§å’Œ T ç»†èƒæ€ä¼¤ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318414" target="_blank" rel="noopener noreferrer">GSE318414 æ—¥å…‰æ€§é›€æ–‘ä¸­è„‚è´¨ä»£è°¢ç´Šä¹±ï¼šå¤šç³»ç»Ÿæ°´å¹³åˆ†ææ­ç¤ºè†œä¸ç¨³å®šæ€§å’Œèƒ½é‡ç¨³æ€ç ´å</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318342" target="_blank" rel="noopener noreferrer">GSE318342 Snail1 é€šè¿‡ EGR1ã€FOXO1 å’Œ CEPBg è¯±å¯¼å¢æ®–æŠ‘åˆ¶ï¼Œä¸ºé¶å‘å‡‹äº¡å’Œç»†èƒè¡°è€é€šè·¯åˆ›é€ äº†è„†å¼±æ€§ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318340" target="_blank" rel="noopener noreferrer">GSE318340 Snail1 é€šè¿‡ EGR1ã€FOXO1 å’Œ CEPBg è¯±å¯¼å¢æ®–æŠ‘åˆ¶ï¼Œä¸ºé¶å‘å‡‹äº¡å’Œç»†èƒè¡°è€é€šè·¯åˆ›é€ äº†è„†å¼±æ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318318" target="_blank" rel="noopener noreferrer">GSE318318 BAF60Cåœ¨2å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨â€”â€”å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318308" target="_blank" rel="noopener noreferrer">GSE318308 ä¸€é¡¹ II æœŸæ¦‚å¿µéªŒè¯ç ”ç©¶ï¼Œè¯„ä¼°åº¦ä¼åˆ©å°¤å•æŠ—å’Œè¥¿åœ°å°¼å¸ƒè”åˆæˆ–ä¸è”åˆå¥¥æ‹‰å¸•å°¼æ²»ç–—å¤å‘æ€§åµå·¢ç™Œçš„ç–—æ•ˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318305" target="_blank" rel="noopener noreferrer">GSE318305 ç”˜æ°¨é…¸é€šè¿‡ GCN2/AKT è½´ä¿ƒè¿›å¿ƒè‚Œç»†èƒå¢æ®–å’Œå¿ƒè„å†ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317978" target="_blank" rel="noopener noreferrer">GSE317978 BAF60Cåœ¨2å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨â€”â€”RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317708" target="_blank" rel="noopener noreferrer">GSE317708 BAF60C åœ¨ 2 å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨ â€”â€”ATAC-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317461" target="_blank" rel="noopener noreferrer">GSE317461 CUET å¤„ç†çš„ç”²çŠ¶è…º 8505 ç»†èƒçš„ç‰¹å¾åˆ†æ (RNA-Seq)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311046" target="_blank" rel="noopener noreferrer">GSE311046 ç¥ç»ç”Ÿé•¿å› å­ (NGF) é©±åŠ¨ ILC2 çš„ä¿ƒè‚¿ç˜¤åŠŸèƒ½ - äººç±» TRKA+ å’Œ TRKA- ILC2 çš„æ‰¹é‡ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291324" target="_blank" rel="noopener noreferrer">GSE291324 å¯¹ä½è‘¡è„ç³–æˆ– MAPKAPK2 è¡¨è¾¾ç¼ºå¤±çš„ HCT116 ç»†èƒè¿›è¡Œè½¬å½•ç»„åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291147" target="_blank" rel="noopener noreferrer">GSE291147 åˆ©ç”¨ PerturbFate ç»˜åˆ¶é»‘è‰²ç´ ç˜¤è€è¯æ€§çš„è¶‹åŒè°ƒæ§å› å­å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289256" target="_blank" rel="noopener noreferrer">GSE289256 é³çŠ¶ç»†èƒè‚ºç™Œçš„å¤šç»„å­¦å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289032" target="_blank" rel="noopener noreferrer">GSE289032 G1-APOL1 éª¨é«“åµŒåˆ B6 å°é¼ å’Œå®Œå…¨ MHC ä¸åŒ¹é…çš„å¼‚ä½å¿ƒè„ç§»æ¤æ’æ–¥ååº”ï¼ˆBALBc-to-B6 æ¨¡å‹ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289030" target="_blank" rel="noopener noreferrer">GSE289030 BACè½¬åŸºå› G1-å’ŒG0-APOL1å°é¼ CD8+Tç»†èƒåœ¨ä½“å¤–åˆºæ¿€åçš„è½¬å½•ç»„ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282078" target="_blank" rel="noopener noreferrer">GSE282078 CAR-M2æ°´å‡èƒ¶æ²»ç–—å¯¹è‚¾çº¤ç»´åŒ–å°é¼ çº¤ç»´åŒ–å’Œå†…çš®è¡€ç®¡ç”Ÿæˆç­‰ç›¸å…³åŸºå› è¡¨è¾¾çš„å½±å“ï¼ˆæ‰¹é‡RNAæµ‹åºï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255194" target="_blank" rel="noopener noreferrer">GSE255194 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [CUT&amp;RUN]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248745" target="_blank" rel="noopener noreferrer">GSE248745 é€šè¿‡åŸä½ APEX2 é©±åŠ¨çš„ç”Ÿç‰©ç´ åŒ–å»ºç«‹åŸå§‹åµæ³¡é˜¶æ®µåµæ¯ç»†èƒè›‹ç™½è´¨ç»„åŠé¡ºé“‚è¯±å¯¼çš„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173800" target="_blank" rel="noopener noreferrer">åˆ©ç”¨æ–°ä¸€ä»£æµ‹åºæŠ€æœ¯è¯„ä¼°AhRå¯¹å°é¼ è‚è„çš„å½±å“ï¼ˆGSE173800ï¼‰</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-06 21:49</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>